Avenliq

Avenliq is a brand name for a medication containing sodium phenylbutyrate. Sodium phenylbutyrate is a drug used to treat urea cycle disorders (UCDs). UCDs are genetic conditions that cause a buildup of ammonia in the blood, which can be toxic to the brain and other organs. Avenliq is an oral liquid formulation of sodium phenylbutyrate, designed to be easier to administer, particularly to children and individuals who have difficulty swallowing pills or tablets. It works by providing an alternative pathway for the body to eliminate excess nitrogen, thereby reducing ammonia levels. Avenliq requires a prescription and is used under the guidance of a healthcare professional specialized in the treatment of metabolic disorders. It is important to note that Avenliq, like all medications, can have potential side effects, and its use should be carefully monitored by a physician.